As a result of using new information technologies, we have selected a catechin from a large number of bioflavonoids that according to the results of docking analysis can form complexes with transthyretin, a protein involved in the pathogenesis of MS, and can also be a potential scavenger of NO, which is also involved in the pathogenesis of MS. The gene discussed is TTR; the disease is myeloid sarcoma.